SCHEMBL30166764

SCHEMBL30166764

Cc1ncc(-c2cc(F)c(C3C(C)C(=O)N3c3ccc4[nH]cnc4c3)c(F)c2)s1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ QPCT Q16769 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24816713 1.00 QPCT (0.42) QPCT
SCHEMBL24815390 1.00 QPCT (0.42) QPCT
SCHEMBL24814385 1.00 QPCT (0.42) QPCT
SCHEMBL25708377 0.96 QPCT (0.41) QPCT
SCHEMBL25708822 0.87 QPCT (0.36) QPCT
SCHEMBL24815716 0.84 QPCT (0.41) QPCT
SCHEMBL30166844 0.84 QPCT (0.41) QPCT
SCHEMBL24816696 0.84 QPCT (0.41) QPCT
SCHEMBL24815787 0.84 QPCT (0.41) QPCT
SCHEMBL26833344 0.84 QPCT (0.41) QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019737-A Beta-lactam derivatives for the treatment of diseases 英矽智能科技知识产权有限公司 2024-05-10 — — CN disclosed
EP-4359405-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES Insilico Medicine IP Limited (HK) 2024-05-01 — — EP disclosed
WO-2022268179-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES INSILICO MEDICINE IP LIMITED (CN) 2022-12-29 — — WO disclosed
Send feedback